SPREBIOTICS
| Page | Code | Product Name | Standardization | Functionality |
|---|---|---|---|---|
| 19 | 1944 | Turmeric Starch (1) New (Curcuma Longa) Starmeric® |
40% Total Starch 20% Resistant Starch |
Anti-inflammatory support Gut Health Prebiotic |
| 19 | 0565 | Fenugreek Fibers (Trigonella foenum-graecum) FenuFibers® |
50% Total Dietary Fiber 15% Protein 2.5% Steroidal Saponins |
Blood sugar support Cholesterol support Glycemic index support Support heart health |
| 19 | 0570 | Fenugreek Extract (Trigonella foenum-graecum) Fenumannans® |
60% Galactomannan | Blood sugar support Digestive support |
SPROBIOTICS
| Page | Code | Product Name | Standardization | Functionality |
|---|---|---|---|---|
| 20 | 1205 | Bacillus coagulans (MTCC 5856) (1,2,3) New (Bacillus coagulans) LactoSpore® GRAS AFFIRMED |
6 Billion Organisms/g | Digestive support Gastrointestinal health General health |
| 20 | 1200 | Bacillus coagulans (MTCC 5856) (1,2,3) New (Bacillus coagulans) LactoSpore® GRAS AFFIRMED |
15 Billion Organisms/g | Digestive support Gastrointestinal health General health |
| 20 | 1201 | Bacillus coagulans (MTCC 5856) (1,2,3) New (Bacillus coagulans) LactoSpore® GRAS AFFIRMED |
100 Billion Organisms/g | Digestive support Gastrointestinal health General health |
SPOSTBIOTICS
| Page | Code | Product Name | Standardization | Functionality |
|---|---|---|---|---|
| 20 | 909 | ImmunoSpore™ New (Bacillus coagulans MTCC 5856) |
15 Billion spores/g count before heat inactivation 1,000 spores/g count after heat inactivation |
Immune support |
SSYNBIOTICS
| Page | Code | Product Name | Standardization | Functionality |
|---|---|---|---|---|
| 20 | 1206 | LactoWise® | 15 Billion Organisms/g 45% Galactomannan 5% Protein |
Digestive support Gastrointestinal health General health |
| 20 | 1101 | LactoCran® (3) New | 2 Billion Organisms/g Organic Cranberry Seed/Juice |
Digestive support Gastrointestinal health General health Healthy Urinary Tract Support |
SPATENTS
(1) LactoSpore® + Turmeric Starch (Starmeric® )
US 10,323,227: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
(2) LactoSpore®
US 9,579,352: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans
US 10,166,261: Bacillus coagulans MTCC 5856 for the management of major depressive disorder
US 10,260,112: Novel PCR Primers and methods thereof for the Identification of Bacillus coagulans MTCC 5856
US 10,293,008; US 9,717,766; AU2015308650; EA034017; MX376004; ZL201580042813.X: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
EP3240553, KR10-2157043: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856
US 10,792,295: Composition for management of Helicobacter pylori infection
US 10,806,760: Compositions and methods for reducing flatulence
(3) LactoCran®
US 9,717,766: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
†Disclaimer
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
